Just more than two years after launching within Alphabet, Isomorphic has inked two large pharma deals with Eli Lilly and Novartis with nearly $3 billion in combined deal value. The two separate pacts add significant weight to Google DeepMind’s AlphaFold AI tech, the foundation of Isomorphic’s platform. The program predicts protein structure, enabling potentially faster […]
